A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer
PHASE3
The aim of BEVAMAINT is to improve benefic effect of maintenance therapy af...
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
PHASE2
The main objective is to evaluate progression-free survival (PFS) at 4 mont...
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal Adenocarcinoma
PHASE3
ARMANI-2/ENGIC8 is a randomized, open-label, phase III trial evaluating a s...